Cargando…

Receptor Tyrosine Kinases — Expanding Horizons

Detalles Bibliográficos
Autor principal:	Hafizi, Sassan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092864/ http://dx.doi.org/10.3390/cells3020657

Ejemplares similares

Expanding horizons
Publicado: (2009)

Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells
por: Al Kafri, Nour, et al.
Publicado: (2020)

Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells
por: Vouri, Mikaella, et al.
Publicado: (2015)

Expanding Horizons in Cancer Imaging
por: Ramaiya, Nikhil H.
Publicado: (2017)

Legacy effect in medicine—the expanding horizon!
por: Wander, Gagandeep Singh, et al.
Publicado: (2018)

Nature-Inspired Drugs: Expanding Horizons of Contemporary Therapeutics
por: Rasul, Azhar, et al.
Publicado: (2019)

Incretin - based therapy in diabetes mellitus: present scenario and expanding horizons
por: Kohli, Suresh Chandra
Publicado: (2016)

Expanding our horizon!
por: Pradhan, Prasanta K
Publicado: (2013)

Orocrinology: Expanding the Horizon
por: Balachandran, Karthik, et al.
Publicado: (2020)

Expanding horizons in medical physics: Standardization to visualization and quantitative assessment based personalized treatments
por: Paliwal, Bhudatt R.
Publicado: (2015)

Tyrosine Kinases in Cancer
por: Blau, Olga, et al.
Publicado: (2015)

Social Pharmacology: Expanding horizons
por: Maiti, Rituparna, et al.
Publicado: (2014)

Expanding Horizons of Diagnostic Imaging
por: Wells, P. N. T.
Publicado: (1988)

Expanding Your Horizon 2017
por: Knapper, Ines, et al.
Publicado: (2017)

Expanding Your Horizon 2015
por: Kaltenhauser, Kristin
Publicado: (2015)

"Expanding Your Horizons" event
por: Mégevand, Guillaume
Publicado: (2013)

Expanding Your Horizons 2011
por: Chromek-Burckhart, Doris
Publicado: (2011)

Expanding Your Horizon 2019
por: Adam Bourdarios, Claire, et al.
Publicado: (2019)

The Variations of MER Receptor Tyrosine Kinase and the Development of Chronic Obstructive Pulmonary Disease
por: Oh, Dong Kyu, et al.
Publicado: (2018)

Transfusion medicine in India: Expanding horizons
por: Marwaha, Neelam
Publicado: (2014)

The Expanding Horizon of Prosthetic Joint Infections
por: Mohajer, Mayar Al, et al.
Publicado: (2014)

Expanding the horizons of microRNA bioinformatics
por: Huntley, Rachael P., et al.
Publicado: (2018)

Expanding horizons of biosciences by light-control
por: Kataoka, Mikio, et al.
Publicado: (2021)

Gene expression in organoids: an expanding horizon
por: Smirnov, Artem, et al.
Publicado: (2023)

New Horizons
por: Dogra, Vikram
Publicado: (2011)

Beyond the horizons
por: Natarajan, Sundaram
Publicado: (2015)

Bruton's tyrosine kinase: oncotarget in myeloma
por: Tai, Yu-Tzu, et al.
Publicado: (2012)

Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready?
por: Tabbò, Fabrizio, et al.
Publicado: (2020)

New horizons in Biophysics
por: Moylan, Elizabeth C
Publicado: (2011)

New Horizons in Diabetology
por: Tootee, Ali, et al.
Publicado: (2016)

Expanding Horizons in Complement Analysis and Quality Control
por: Frazer-Abel, Ashley, et al.
Publicado: (2021)

Clinical Utility of Mifepristone: Apprising the Expanding Horizons
por: Karena, Zalak V, et al.
Publicado: (2022)

Commentary: Expanding the horizons of red-free examination
por: Soni, Tanvi, et al.
Publicado: (2022)

Commentary: Behçet’s uveitis – Expanding treatment horizons
por: Moreker, Mayur R
Publicado: (2023)

Expanding Nuclear Physics Horizons with the Gamma Factory
por: Budker, Dmitry, et al.
Publicado: (2021)

Fasting plus tyrosine kinase inhibitors in cancer
por: Caffa, Irene, et al.
Publicado: (2015)

Axl-EGFR receptor tyrosine kinase hetero-interaction provides EGFR with access to pro-invasive signalling in cancer cells
por: Vouri, M, et al.
Publicado: (2016)

Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
por: Zhang, Shannon S., et al.
Publicado: (2022)

HORIZON I: Is there a future for oral anti-angiogenics on the horizon of colorectal cancer therapy?
por: Hochster, H S
Publicado: (2013)

What Is on the Horizon?
por: Nair, P. N. Ramachandran
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0fjq277ckk5krn7i2c7n8rhgij